Pieris Pharmaceuticals Inc (PIRS)
11.08
-0.30
(-2.59%)
USD |
NASDAQ |
May 03, 16:00
11.08
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Max Drawdown (5Y): 97.61% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 97.61% |
| March 31, 2024 | 97.61% |
| February 29, 2024 | 97.61% |
| January 31, 2024 | 97.61% |
| December 31, 2023 | 97.61% |
| November 30, 2023 | 97.18% |
| October 31, 2023 | 97.18% |
| September 30, 2023 | 97.18% |
| August 31, 2023 | 97.18% |
| July 31, 2023 | 97.18% |
| June 30, 2023 | 97.18% |
| May 31, 2023 | 90.07% |
| April 30, 2023 | 90.07% |
| March 31, 2023 | 90.07% |
| February 28, 2023 | 90.07% |
| January 31, 2023 | 90.07% |
| December 31, 2022 | 90.07% |
| November 30, 2022 | 90.04% |
| October 31, 2022 | 89.42% |
| September 30, 2022 | 88.25% |
| August 31, 2022 | 84.55% |
| July 31, 2022 | 83.28% |
| June 30, 2022 | 83.28% |
| May 31, 2022 | 82.96% |
| April 30, 2022 | 82.96% |
| Date | Value |
|---|---|
| March 31, 2022 | 82.96% |
| February 28, 2022 | 82.96% |
| January 31, 2022 | 82.96% |
| December 31, 2021 | 82.96% |
| November 30, 2021 | 82.96% |
| October 31, 2021 | 82.96% |
| September 30, 2021 | 82.96% |
| August 31, 2021 | 82.96% |
| July 31, 2021 | 82.96% |
| June 30, 2021 | 82.96% |
| May 31, 2021 | 82.96% |
| April 30, 2021 | 82.96% |
| March 31, 2021 | 82.96% |
| February 28, 2021 | 82.96% |
| January 31, 2021 | 82.96% |
| December 31, 2020 | 82.96% |
| November 30, 2020 | 82.96% |
| October 31, 2020 | 82.96% |
| September 30, 2020 | 82.96% |
| August 31, 2020 | 82.96% |
| July 31, 2020 | 82.96% |
| June 30, 2020 | 82.96% |
| May 31, 2020 | 82.96% |
| April 30, 2020 | 82.96% |
| March 31, 2020 | 82.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.97%
Minimum
May 2019
97.61%
Maximum
Dec 2023
85.17%
Average
82.96%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -53.52 |
| Beta (5Y) | 0.5534 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.72% |
| Historical Sharpe Ratio (5Y) | -0.5337 |
| Historical Sortino (5Y) | -0.8615 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.52% |